Evidence map›Paper›PMID 38721407›Full record

ArticleJournal of immunotherapy and precision oncology2024

Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1.

Anagha Deshpande, Javier Munoz, Vrushali Dabak, Amr Hanbali, Razelle Kurzrock

Abstract readCase Reports
In one paragraph

Article in Journal of immunotherapy and precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anagha DeshpandeMayo Clinic Alix School of Medicine, Scottsdale, AZ, USA.ORCID https://orcid.org/0000-0002-5653-2837
Javier MunozDepartment of Hematology, Mayo Clinic Arizona, Phoenix, AZ, USA.
Vrushali DabakDepartment of Hematology and Oncology, Henry Ford Health System, Detroit, MI, USA.
Amr HanbaliDepartment of Hematology and Cellular Therapy, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Razelle KurzrockMedical College of Wisconsin, Milwaukee, WI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder that primarily causes the growth of tumors along nerves. Additionally, the germline mutations involved in NF1 predispose patients to develop further malignancies. The mainstay initial treatment for these malignancies is surgical removal at diagnosis, although targeted therapies are under evaluation in the relapsed setting. We report a case of malignant peripheral nerve sheath tumor (MPNST), gastrointestinal stromal tumor (GIST), and pheochromocytoma in a patient with NF1 who presented with an infected right shoulder lesion that was confirmed to be spindle cell sarcoma via biopsy. She was treated with antibiotics; however, she rapidly deteriorated and opted for hospice care.

Indexed as

case reportgastrointestinal stromal tumormalignant peripheral nerve sheath tumorneurofibromatosispheochromocytoma

Identifiers

PMID38721407
PMCPMC11075472

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.